As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
HOME > COLUMN
COLUMN
-
Is Your Company Culture Being a Victim of COVID-19?
January 8, 2021
-
It’s the Everyday Leaders Your Organization Needs
December 11, 2020
-
Let’s Be Grateful for the Chaos of the Year That Was
November 18, 2020
-
Empower Smarter Decision Making with Big Data
October 23, 2020
-
5 Improvements when Recruiting Female Employees
September 25, 2020
-
Think Differently for Post-Pandemic Success
August 14, 2020
-
The Crisis That Ignited a Workplace Revolution
July 6, 2020
-
Smart Strategies for Building Your Dream Team
March 17, 2020
-
A Peek into the Digital Pharmaceutical Industry
November 21, 2019
-
Plant the Seeds of Success when Battling a Crisis
September 30, 2019
-
Practice Makes Perfect - Even in Marketing!
August 19, 2019
-
Failing Isn’t the Issue. What You Do Next Is All that Counts
July 26, 2019
-
Big Question Mark to Pricey Drug Bashing
July 12, 2019
-
The Science Behind Stage Fright, and How You Can Overcome It
June 28, 2019
-
The Power in Teaching Your Team “How to Speak”
May 28, 2019
-
Unlock Hidden Talent by Hiring for These Four Traits
May 10, 2019
-
No Drug “Reviews” for 1st Time in 2 Years
April 22, 2019
-
6 Core Elements of Recruitment Mastery
March 22, 2019
-
Is Japan’s Cost-Effectiveness Assessment Scheme Cost Effective?
February 27, 2019
-
Why Top-Tier Recruiters Must Embrace Their Creative Side
January 31, 2019
ページ
A total of 43 innovative new medicines are anticipated to be approved or listed in Japan this year, according to a survey by Jiho. At the center of attention are some highly innovative, but probably ultra-expensive, gene therapies, as well…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…